Q1 2025 · CIK 1489933 Snapshot · — Export CSV
Manager file · GLRE · DME Capital Management, LP

David Einhorn - Greenlight Capital

EDGAR CIK 1489933 ↗ · Waiting · typical filing lag 45 days · EDGAR name DME Capital Management, LP (Greenlight Capital, David Einhorn); Greenlight Capital Inc (1079114) last 13F 2024-02-14

Export CSV
Reported portfolio value
$1.97B
QoQ reported +1.6% · vs Q4 2024
Positions
33
2 new · 5 exited
Top 10 concentration
76.5%
largest position 28.0%
Position churn · Q1 2025
13 added · 9 trimmed
new positions 10.3% · exits 0.0% of book
Holdings · Q1 2025 · 33
Security Weight Δ wt Price* Shares Δ shares Value Action
1 GRBK GREEN BRICK PARTNERS INC 27.96% +0.5% $58 9.47M +0.0% $552M Held
2 CNR CORE NATURAL RESOURCES INC 8.62% +8.6% $77 2.21M new $170M New
3 BHF BRIGHTHOUSE FINL INC 8.23% +1.2% $58 2.80M -1.2% $162M Trimmed
4 KD KYNDRYL HLDGS INC 6.58% -0.1% $31 4.14M +9.9% $130M Added
5 PENN PENN ENTERTAINMENT INC 5.18% -0.7% $16 6.27M +9.0% $102M Added
6 — CNH INDL N V 5.02% -0.9% $12 8.08M -21.1% $99.18M Trimmed
7 HPQ HP INC 4.23% +0.7% $28 3.02M +43.0% $83.59M Added
8 TECK TECK RESOURCES LTD 3.69% +1.4% $36 2.00M +84.0% $72.86M Added
9 — DHT HOLDINGS INC 3.52% +1.0% $10 6.61M +26.0% $69.41M Added
10 — CAPRI HOLDINGS LIMITED 3.48% +1.2% $20 3.48M +65.4% $68.64M Added
11 — LIBERTY GLOBAL LTD 3.04% +0.5% $12 5.22M +34.4% $60.09M Added
12 — ROIVANT SCIENCES LTD 2.78% -0.4% $10 5.44M +3.2% $54.90M Added
13 VTRS VIATRIS INC 2.65% -1.1% $9 6.00M +3.7% $52.27M Added
14 GLD SPDR GOLD TR 2.63% +0.1% $288 180K -10.8% $51.91M Trimmed
15 — SEADRILL LTD 2.01% +0.5% $25 1.59M +106.8% $39.72M Added
16 CNC CENTENE CORP DEL 1.68% -1.0% $61 548K -37.1% $33.24M Trimmed
17 DLTR DOLLAR TREE INC 1.66% +1.7% $75 436K new $32.76M New
18 PTON PELOTON INTERACTIVE INC 1.60% -3.1% $6 5.00M -52.5% $31.62M Trimmed
19 GPK GRAPHIC PACKAGING HLDG CO 1.38% -0.1% $26 1.05M +0.0% $27.18M Held
20 — WEATHERFORD INTL PLC 1.24% -0.4% $54 457K +0.0% $24.45M Held
21 LKFT GALAPAGOS NV 0.61% -0.1% $25 483K +0.7% $12.13M Added
22 COYA COYA THERAPEUTICS INC 0.54% +0.1% $6 1.65M +0.0% $10.65M Held
23 TEVAN TEVA PHARMACEUTICAL INDS LTD 0.44% -0.1% $15 568K +21.3% $8.73M Added
24 ALITEUR ALIGHT INC 0.30% -0.9% $6 1.00M -70.2% $5.93M Trimmed
25 SNX TD SYNNEX CORPORATION 0.24% -0.1% $104 46K -14.1% $4.80M Trimmed
26 ACHC ACADIA HEALTHCARE COMPANY IN 0.19% -0.1% $30 121K -6.0% $3.66M Trimmed
27 GDX VANECK ETF TRUST 0.18% -0.0% $46 76K -31.4% $3.51M Trimmed
28 OIH VANECK ETF TRUST 0.16% +0.1% $262 12K +120.3% $3.24M Added
29 GPRO GOPRO INC 0.09% -0.1% $1 2.82M +0.0% $1.87M Held
30 GANX GAIN THERAPEUTICS INC 0.05% -0.0% $2 566K +0.0% $1.08M Held
31 NUVB NUVATION BIO INC 0.00% -0.0% $2 35K +0.0% $61.59K Held
32 NUVB/WS NUVATION BIO INC 0.00% +0.0% $0 100K +0.0% $32.00K Held
33 — KATAPULT HOLDINGS INC 0.00% +0.0% $0 262K +0.0% $2.33K Held
34 — CONSOL ENERGY INC NEW 0.00% -7.7% — 0 1.39M → 0 $0 Exited
35 RSP INVESCO EXCHANGE TRADED FD T 0.00% -0.2% — 0 28K → 0 $0 Exited
36 XRT SPDR SER TR 0.00% -0.2% — 0 60K → 0 $0 Exited
37 FCG FIRST TR EXCHANGE-TRADED FD 0.00% -0.1% — 0 71K → 0 $0 Exited
38 PDBC INVESCO ACTVELY MNGD ETC FD 0.00% -0.1% — 0 117K → 0 $0 Exited

* Price = reported value ÷ shares at quarter end (13F does not disclose cost basis). Δ wt = this position's share of the reported portfolio versus the prior quarter. Options are shown separately when filed.

This quarter's moves
  • CORE NATURAL RESOURCES INC 8.62% · $170M
  • DOLLAR TREE INC 1.66% · $32.76M
  • CONSOL ENERGY INC NEW was 7.65% · 1.39M sh
  • INVESCO EXCHANGE TRADED FD T was 0.25% · 28K sh
  • SPDR SER TR was 0.24% · 60K sh
  • FIRST TR EXCHANGE-TRADED FD was 0.09% · 71K sh
  • INVESCO ACTVELY MNGD ETC FD was 0.08% · 117K sh
  • Filing detail
    Period2025-03-31
    Accepted15 May 2025 · 16:01 ET
    Filing lag45 days
    Form13F-HR
    Information rows68
    Quarters on file10
    Portfolio value
    Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026$3.91B Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 202646
    Quarterly history · 10 filings
    QuarterPeriod endReported valuePositionsLargestNewExitedFiledLag
    Q2 2026 2026-06-30 $3.91B 46 19.4% 7 6 14 Aug 2026 ET 45
    Q1 2026 2026-03-31 $3.19B 45 19.1% 11 7 15 May 2026 ET 45
    Q4 2025 2025-12-31 $2.85B 41 20.8% 8 4 17 Feb 2026 ET 48
    Q3 2025 2025-09-30 $2.54B 37 27.5% 4 1 14 Nov 2025 ET 45
    Q2 2025 2025-06-30 $2.33B 34 25.6% 4 3 14 Aug 2025 ET 45
    Q1 2025 2025-03-31 $1.97B 33 28.0% 2 5 15 May 2025 ET 45
    Q4 2024 2024-12-31 $1.94B 36 27.5% 5 7 14 Feb 2025 ET 45
    Q3 2024 2024-09-30 $2.40B 38 32.9% 1 2 14 Nov 2024 ET 45
    Q2 2024 2024-06-30 $2.04B 39 29.3% 3 6 14 Aug 2024 ET 45
    Q1 2024 2024-03-31 $2.18B 42 28.9% — — 15 May 2024 ET 45
    Track record · return since filing
    Paper return of each reported book
    Since Q1 2024
    +10.0%
    S&P 500 +44.3%
    Hit rate · latest book
    32%
    priced positions with positive return
    Priced coverage
    85%
    of reported stock value
    Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Reported bookS&P 500
    Quarter by quarter
    QuarterBookS&P 500ExcessCoverageBest call
    Q2 2026 -8.3% -4.1% -4.1% 85% ACHC +24.7%
    Q1 2026 +5.5% +0.9% +4.5% 86% VSXY +119.9%
    Q4 2025 +2.0% +9.6% -7.6% 80% CNC +81.4%
    Q3 2025 +5.2% +11.7% -6.5% 81% VSXY +183.2%
    Q2 2025 +4.5% +16.7% -12.2% 78% CNC +177.8%
    Q1 2025 +4.0% +27.8% -23.8% 78% VTRS +150.4%
    Q4 2024 -5.6% +24.1% -29.7% 71% VTRS +106.4%
    Q3 2024 -4.4% +28.0% -32.4% 71% VTRS +78.2%
    Q2 2024 +6.1% +40.1% -34.0% 71% VTRS +99.3%
    Q1 2024 +10.0% +44.3% -34.2% 70% THC +118.7%
    Copy-trade simulation
    Hypothetical strategy
    +11.5%
    10 rebalances
    S&P 500 same window
    +44.3%
    excess -32.7%

    Simulation: at each filing date, buy the manager's ten largest reported common-stock positions in equal weight; hold until the next filing. Prices are split- and dividend-adjusted closes. It ignores the 45-day disclosure lag's cost to a real copycat beyond the filing-date entry, taxes, fees and liquidity. It is a reading aid, not a backtest of the manager's fund.